Wockhardt incorporates step-down subsidiary in Ireland

Wockhardt [BSE: 532300] announced today the incorporation of Wockhardt Antibiotics (Ireland) Limited, a new wholly-owned step-down subsidiary, via its subsidiary Wockhardt Bio AG. The new entity, established in Ireland on April 7, 2025, has an initial capital of EUR 100 divided into 100 shares at EUR 1 each. Wockhardt stated that this move aligns with its business objectives and aims to streamline its antibiotic product distribution across the European Union. The company confirmed that no governmental or regulatory approvals were required for the incorporation. This information is provided in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.